ArticleCancer & metabolism2025

CD36 inhibition enhances the anti-proliferative effects of PI3K inhibitors in PTEN-loss anti-HER2 resistant breast cancer cells.

You-Yu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.